Up-regulation of SENP1 promotes deSUMOylation of SMAD4 in prostate cancer cells, which reduces the SMAD4 levels and impairs TGF-β/SMADs-mediated transcription activities. This evidence concerns the gene SMAD4 and Familial prostate cancer.